Literature DB >> 20408893

DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Cornelia H Rinderknecht1, Sujin Roh, Achal Pashine, Michael P Belmares, Namrata S Patil, Ning Lu, Phi Truong, Tieying Hou, Claudia Macaubas, Taejin Yoon, Nan Wang, Robert Busch, Elizabeth D Mellins.   

Abstract

DM catalyses class II-associated invariant chain peptide (CLIP) release, edits the repertoire of peptides bound to major histocompatibility complex (MHC) class II molecules, affects class II structure, and thereby modulates binding of conformation-sensitive anti-class II antibodies. Here, we investigate the ability of DM to enhance the cell surface binding of monomorphic antibodies. We show that this enhancement reflects increases in cell surface class II expression and total cellular abundance, but notably these effects are selective for particular alleles. Evidence from analysis of cellular class II levels after cycloheximide treatment and from pulse-chase experiments indicates that DM increases the half-life of affected alleles. Unexpectedly, the pulse-chase experiments also revealed an early effect of DM on assembly of these alleles. The allelically variant feature that correlates with susceptibility to these DM effects is low affinity for CLIP; DM-dependent changes in abundance are reduced by invariant chain (CLIP) mutants that enhance CLIP binding to class II. We found evidence that DM mediates rescue of peptide-receptive DR0404 molecules from inactive forms in vitro and evidence suggesting that a similar process occurs in cells. Thus, multiple mechanisms, operating along the biosynthetic pathway of class II molecules, contribute to DM-mediated increases in the abundance of low-CLIP-affinity alleles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20408893      PMCID: PMC2966754          DOI: 10.1111/j.1365-2567.2010.03282.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  94 in total

1.  Transmembrane domain-mediated colocalization of HLA-DM and HLA-DR is required for optimal HLA-DM catalytic activity.

Authors:  D A Weber; C T Dao; J Jun; J L Wigal; P E Jensen
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

Review 2.  Folding of newly translated proteins in vivo: the role of molecular chaperones.

Authors:  J Frydman
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

3.  Structural factors contributing to DM susceptibility of MHC class II/peptide complexes.

Authors:  Michael P Belmares; Robert Busch; Kai W Wucherpfennig; Harden M McConnell; Elizabeth D Mellins
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

4.  Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM.

Authors:  Michael P Belmares; Robert Busch; Elizabeth D Mellins; Harden M McConnell
Journal:  Biochemistry       Date:  2003-01-28       Impact factor: 3.162

5.  Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides.

Authors:  Achal Pashine; Robert Busch; Michael P Belmares; Jason N Munning; Robert C Doebele; Megan Buckingham; Gary P Nolan; Elizabeth D Mellins
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

6.  Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.

Authors:  N S Patil; A Pashine; M P Belmares; W Liu; B Kaneshiro; J Rabinowitz; H McConnell; E D Mellins
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

7.  Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes.

Authors:  Frances C Hall; Joshua D Rabinowitz; Robert Busch; Kevin C Visconti; Michael Belmares; Namrata S Patil; Andrew P Cope; Salil Patel; Harden M McConnell; Elizabeth D Mellins; Grete Sonderstrup
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

8.  DM loss in k haplotype mice reveals isotype-specific chaperone requirements.

Authors:  Chad H Koonce; Gordana Wutz; Elizabeth J Robertson; Anne B Vogt; Harald Kropshofer; Elizabeth K Bikoff
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

9.  Editing of an immunodominant epitope of glutamate decarboxylase by HLA-DM.

Authors:  John D Lich; Jennifer A Jayne; Delu Zhou; John F Elliott; Janice S Blum
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

10.  Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.

Authors:  Karen Honey; Katherine Forbush; Peter E Jensen; Alexander Y Rudensky
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

View more
  16 in total

1.  Epitope Selection for HLA-DQ2 Presentation: Implications for Celiac Disease and Viral Defense.

Authors:  Shu-Chen Hung; Tieying Hou; Wei Jiang; Nan Wang; Shuo-Wang Qiao; I-Ting Chow; Xiaodan Liu; Sjoerd H van der Burg; David M Koelle; William W Kwok; Ludvig M Sollid; Elizabeth D Mellins
Journal:  J Immunol       Date:  2019-03-29       Impact factor: 5.422

2.  I-Ag7 is subject to post-translational chaperoning by CLIP.

Authors:  Cornelia H Rinderknecht; Ning Lu; Oliver Crespo; Phi Truong; Tieying Hou; Nan Wang; Narendiran Rajasekaran; Elizabeth D Mellins
Journal:  Int Immunol       Date:  2010-06-13       Impact factor: 4.823

3.  An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations.

Authors:  Tieying Hou; Henriette Macmillan; Zhenjun Chen; Catherine L Keech; Xi Jin; John Sidney; Michael Strohman; Taejin Yoon; Elizabeth D Mellins
Journal:  J Immunol       Date:  2011-07-20       Impact factor: 5.422

4.  The MHC class II cofactor HLA-DM interacts with Ig in B cells.

Authors:  Henriette Macmillan; Michael J Strohman; Sashi Ayyangar; Wei Jiang; Narendiran Rajasekaran; Armin Spura; Ann J Hessell; Anne-Marie Madec; Elizabeth D Mellins
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

Review 5.  Exogenous antigens bind MHC class II first, and are processed by cathepsins later.

Authors:  Scheherazade Sadegh-Nasseri; AeRyon Kim
Journal:  Mol Immunol       Date:  2015-08-05       Impact factor: 4.407

Review 6.  HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications.

Authors:  Robert Busch; Simon Kollnberger; Elizabeth D Mellins
Journal:  Nat Rev Rheumatol       Date:  2019-06       Impact factor: 20.543

7.  Pulse-chase analysis for studies of MHC class II biosynthesis, maturation, and peptide loading.

Authors:  Tieying Hou; Cornelia H Rinderknecht; Andreas V Hadjinicolaou; Robert Busch; Elizabeth Mellins
Journal:  Methods Mol Biol       Date:  2013

8.  Accelerated turnover of MHC class II molecules in nonobese diabetic mice is developmentally and environmentally regulated in vivo and dispensable for autoimmunity.

Authors:  Alessandra De Riva; Mark C Varley; Leslie J Bluck; Anne Cooke; Michael J Deery; Robert Busch
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

9.  HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.

Authors:  Abigail I Guce; Sarah E Mortimer; Taejin Yoon; Corrie A Painter; Wei Jiang; Elizabeth D Mellins; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2012-12-09       Impact factor: 15.369

10.  pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity.

Authors:  Wei Jiang; Michael J Strohman; Sriram Somasundaram; Sashi Ayyangar; Tieying Hou; Nan Wang; Elizabeth D Mellins
Journal:  Sci Rep       Date:  2015-11-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.